Recombinant Proteins Market Size & Share, by Host Cell (Insect Cells, Mammalian); Application (Research, Therapeutics, Healthcare) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4632
  • Published Date: Apr 17, 2023
  • Report Format: PDF, PPT

Companies Dominating the Recombinant Proteins Landscape

top-features-companies
    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck KGaA
    • Lonza Group AG
    • GenScript Biotech Corporation
    • AbbVie Inc.
    • Amgen Inc.
    • Roche Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA

     


Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Merck KGaA: Merck announced that it had signed an agreement to acquire AmpTec, a leading provider of high-quality RNA and mRNA for research and commercial applications. The acquisition will strengthen Merck's capabilities in the field of mRNA-based therapeutics and vaccines.

  • Roche Holdings Inc.: Roche announced that it had received approval from the US Food and Drug Administration (FDA) for its recombinant protein Hemlibra, for the treatment of hemophilia A in patients without factor VIII inhibitors. Hemlibra is a bispecific antibody designed to bring together factors IXa and X, which are needed to activate the natural coagulation cascade and restore the blood clotting process.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4632
  • Published Date: Apr 17, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing investments in development of biopharmaceuticals and recombinant proteins, and growing prevalence of genetic rare diseases are the major factors driving the market growth.

The market size of recombinant proteins is anticipated to attain a CAGR of 12.80% over the forecast period, i.e., 2023-2035.

The limited availability of manufacturing capacity is estimated to be the growth hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, GenScript Biotech Corporation, AbbVie Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by host cell, application, and by region.

The healthcare segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying